Cite
HARVARD Citation
Ritchie, C. et al. (n.d.). P4‐388: XANAMEMTM: A Novel 11B‐HSD1 Inhibitor with Potential to Provide Durable Symptomatic and Disease Modifying Benefits in Alzheimer'S Disease. Alzheimer's & dementia. p. P1186. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ritchie, C. et al. (n.d.). P4‐388: XANAMEMTM: A Novel 11B‐HSD1 Inhibitor with Potential to Provide Durable Symptomatic and Disease Modifying Benefits in Alzheimer'S Disease. Alzheimer's & dementia. p. P1186. [Online].